BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 1394063)

  • 21. Noncutaneous T-cell lymphomas. Recognition of a lymphoma type (large cell anaplastic) with a relatively favorable prognosis.
    de Bruin PC; Noorduyn AL; van der Valk P; van Heerde P; van Diest PJ; van de Sandt MM; Ossenkoppele GJ; Meijer CJ
    Cancer; 1993 Apr; 71(8):2604-12. PubMed ID: 8453584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Head-and-neck stages I and II extranodal non-Hodgkin's lymphomas: real classification and selection for treatment modality.
    Sasai K; Yamabe H; Kokubo M; Shibata T; Oya N; Nagata Y; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):153-60. PubMed ID: 10924985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of neoplastic and reactive cell proliferation in non-Hodgkin's lymphomas linked to patient survival.
    Ffrench M; Magaud JP; Ffrench P; Berger F; Devaux Y; Duhaut P; Shen N; Coiffier B; Bryon PA
    Am J Clin Pathol; 1994 Apr; 101(4):413-20. PubMed ID: 8160629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunophenotypic analysis of extranodal non-Hodgkin's lymphomas in the oral cavity.
    Takahashi H; Fujita S; Okabe H; Tsuda N; Tezuka F
    Pathol Res Pract; 1993 Apr; 189(3):300-11. PubMed ID: 8332573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary malignant lymphoma of the intestine: clinicopathologic and immunohistochemical studies of 39 cases.
    Kojima M; Nakamura S; Kurabayashi Y; Shimizu K; Hosomura Y; Ohno Y; Itoh H; Yoshida K; Sano T; Sakurai S
    Pathol Int; 1995 Feb; 45(2):123-30. PubMed ID: 7742924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological heterogeneity of diffuse mixed small and large cell non-Hodgkin's lymphomas assessed by DNA flow cytometry and Ki67.
    Palestro G; Pich A; Chiusa L; Geuna M; Ponti R; Kerim S; Novero D; Valente G
    Leuk Lymphoma; 1995 Nov; 19(5-6):467-72. PubMed ID: 8590848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
    Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
    J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A clinicopathologic study of 233 cases with special reference to evaluation with the MIB-1 index.
    Nakamura S; Akazawa K; Yao T; Tsuneyoshi M
    Cancer; 1995 Oct; 76(8):1313-24. PubMed ID: 8620403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relevance of Ki-67 expression in the classification of non-Hodgkin's lymphomas: a morphometric and double-immunostaining study.
    Houmand A; Abrahamsen B; Tinggaard Pedersen N
    Histopathology; 1992 Jan; 20(1):13-20. PubMed ID: 1737622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
    Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
    Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural killer cell subsets and natural killer-like T-cell populations in benign and neoplastic B-cell proliferations vary based on clinicopathologic features.
    Gibson SE; Swerdlow SH; Felgar RE
    Hum Pathol; 2011 May; 42(5):679-87. PubMed ID: 21292303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial.
    Miller TP; Grogan TM; Dahlberg S; Spier CM; Braziel RM; Banks PM; Foucar K; Kjeldsberg CR; Levy N; Nathwani BN
    Blood; 1994 Mar; 83(6):1460-6. PubMed ID: 8123837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early and reliable diagnosis of non-Hodgkin lymphoma in childhood and adolescence: contribution of cytomorphology and flow cytometric immunophenotyping.
    Mann G; Attarbaschi A; Steiner M; Simonitsch I; Strobl H; Urban C; Meister B; Haas O; Dworzak M; Gadner H;
    Pediatr Hematol Oncol; 2006; 23(3):167-76. PubMed ID: 16526117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.
    Miller DC; Hochberg FH; Harris NL; Gruber ML; Louis DN; Cohen H
    Cancer; 1994 Aug; 74(4):1383-97. PubMed ID: 8055462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen.
    Kreipe H; Wacker HH; Heidebrecht HJ; Haas K; Hauberg M; Tiemann M; Parwaresch R
    Am J Pathol; 1993 Jun; 142(6):1689-94. PubMed ID: 7685150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pathologic study of childhood lymphoma in Taiwan with special reference to peripheral T-cell lymphoma and the association with Epstein-Barr viral infection.
    Lee SH; Su IJ; Chen RL; Lin KS; Lin DT; Chuu WM; Lin KS
    Cancer; 1991 Nov; 68(9):1954-62. PubMed ID: 1655230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary non-Hodgkin lymphomas of the CNS. Classification, tissue reaction and proliferative activity.
    Bergmann M; Kuchelmeister K; Edel G; Heinecke A
    Zentralbl Pathol; 1993 Mar; 139(1):37-44. PubMed ID: 8098955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma.
    Witzig TE; Maurer MJ; Habermann TM; Link BK; Micallef IN; Nowakowski GS; Ansell SM; Colgan JP; Inwards DJ; Porrata LF; Markovic SN; Johnston PB; Lin Y; Thompson C; Gupta M; Katzmann JA; Cerhan JR
    Am J Hematol; 2014 Dec; 89(12):1116-20. PubMed ID: 25228125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphoma.
    Llanos M; Alvarez-Argüelles H; Alemán R; Oramas J; Diaz-Flores L; Batista N
    Med Oncol; 2001; 18(1):15-22. PubMed ID: 11778965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.